HOME › DRUGS › PALOPEGTERIPARATIDE
ACTIVE SUBSTANCE / INN

PALOPEGTERIPARATIDE

Brand name(s): Yorvipath, YORVIPATH
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Hypoparathyroidism
NDA216490
ACTIVE SUBSTANCE
Palopegteriparatide
REGULATORS
FDA · EMA
SPONSORS / MAH
ASCENDIS PHARMA BONE, Ascendis Pharma Bone Diseases A/S
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
YORVIPATHNDA216490ASCENDIS PHARMA BONEPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
YorvipathAscendis Pharma Bone Diseases A/SAuthorised17/11/2023Hypoparathyroidism

FULL INTELLIGENCE ON PALOPEGTERIPARATIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →